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1. Introduction 
Congenital vascular malformation (CVM) refers to malformed vessels resulting from 
arrested development during various stages of embryogenesis and presents in about 1.5% of 
the population (Belov, 1989; Malan & Pulionisi, 1965; Villavicencio et al, 2002). The CVMs 
may originate from multiple vascular systems, including arterial, venous, and lymphatic, 
and represent as either a predominant form (e.g., arterial malformation) or as a mixed 
condition (venolymphatic malformation). As such, CVM has various clinical manifestations 
depending on vascular structural architecture, involved site(s), and type of malformed 
vessels present. In general, most CVMs are sporadic, but some are heritable in an autosomal 
dominant fashion (Arneja & Gosain, 2008). In spite of advances in the field of vascular 
biology, the pathogenesis, natural history, and treatment principles of CVMs have yet to be 
understood or developed. 
Occasionally, CVMs can be confused with infantile hemangiomas (Figure 1). Even though 
both anomalies represent cutaneous vascular manifestations, their histologic findings and 
clinical courses are completely different. Most hemangiomas appear at birth, are self-limited, 
and resolve spontaneously before 12 years of age. However, CVMs may be identified at birth, 
progress during childhood, and never regress during the lifespan (Figure 1).  
Clinical manifestations of the CVM are determined by its embryologic characteristics, 
especially the stage of embryogenesis in which development was arrested. Thus, it 
represents a wide range of clinical symptoms from a simple birthmark to a life-threatening 
condition (Lee, 2005). A small, localized venous malformation may cause a simple cosmetic 
problem such as a birthmark; however, a diffuse type of arteriovenous malformation in a 
major organ may result in a life-threatening condition, such as congestive heart failure, 
intractable bleeding, or airway obstruction, in addition to serious disfigurement.  
Despite diagnostic advances over the last three decades, it is very difficult to diagnose the 
CVM for a sole physician because the CVM may involve multiple vascular systems and 
manifest variable clinical presentations. Therefore, multidisciplinary collaboration of 
physicians from special departments is necessary for accurate diagnosis and successful 
treatment of CVM.  
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Fig. 1. Hemangioma and congenital vascular malformation. A, hemangioma in left back. B, 
venous malformation in right buttock. 
Currently, complete excision of the nidus has been known as the only therapeutic modality 
for a cure of the CVM. However, complete surgical removal is nearly impossible because 
most CVMs are diffuse and of an infiltrative nature. 
As an alternative treatment method, embolo/sclerotherapy may be an effective modality 
and successful in most CVMs, in particular the diffuse and infiltrative types. We previously 
reported that the incidence, the susceptible types, and the outcomes for skin and soft tissue 
injuries of embolo/sclerotherapy in CVMs (Lee et al., 2008). 
This chapter reviews the general aspect of the CVMs and, based on our study, expands 
the incidence and treatment methods, including skin graft, in addition to the prognosis 
of skin and soft tissue injuries developed after embolo/sclerotherpay in patients with 
CVMs. 
2. Congenital vascular malformations: General aspect 
2.1 Classification 
A proper classification of CVMs is very difficult since they develop as a result of arrest 
during various embryologic stages and represent a variety of clinical manifestations.  
Over the centuries, various CVMs have been labeled with name-based eponyms, such as 
Klippel-Trenaunay or Parkes Weber syndromes. However, these eponyms were defined 
by only clinically relevant manifestations (e.g., birthmark, swelling, disfigurement) and 
did not identify the primary vascular lesion and/or other nonvascular anomalies. 
Although these old name-based eponyms have been replaced by new classifications based 
on anatomic and pathophysiologic status as well as clinically relevant manifestations, 
these are still valuable for understanding the cutaneous lesions of CVM, as well for the 
historical significance. For instance, Klippel-Trenaunay syndrome, which is characterized 
by cutaneous hemangiomas, soft tissue hypertrophy, and varicosities, can be replaced 
with hemolymphatic malformation in the Hamburg classification (Figure 2). However, as 
its historical eponym is well known, it can still be used to represent the cutaneous 
manifestations. 
A B 
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Fig. 2. Klippel-Trenaunay syndrome. A, Gross appearance. B, Ascending venogram. C, 
Whole body blood pool scan. 
2.1.1 Hamburg classification 
In 1988, the ISSVA (International Society for the Study of Vascular Anomalies) that was held 
in Hamburg, Germany, has adopted the new classification of CVMs based on the 
A B 
C 
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underlying anatomic, histologic, pathophysiologic, and hemodynamic status (Belov, 1989, 
1990; Lee et al., 2007). This classification has been considered to be clinically applicable and 
is regarded as a modern system. In the Hamburg classification, CVMs are divided into five 
types based on the predominant vascular defect: arterial, venous, arteriovenous shunting, 
lymphatic, and combined (Table 1). Each type was subclassified into a truncal form and 
extratruncal form depending on the embryonic stage of developmental arrest (Lee, 2005). 
The initial classification system did not contain the capillary malformation, since their 
clinical significance had been considered uncertain. However, the addition of capillary 
malformation was subsequently proposed and supported.  
 
Types Embyologic subtypes 
Predominantly arterial defects Truncular forms 
      Aplasia or obstruction 
      Dilatation 
 Extratruncular forms 
      Infiltrating 
      Limited 
Predominantly venous defects Truncular forms 
      Aplasia or obstruction 
      Dilatation 
 Extratruncular forms 
      Infiltrating 
      Limited 
Predominantly AV shunting defects Truncular forms 
      Deep 
      Superficial 
 Extratruncular forms 
      Infiltrating 
      Limited 
Predominantly lymphatic defects Truncular forms 
      Aplasia or obstruction 
      Dilatation 
 Extratruncular forms 
      Infiltrating 
      Limited 
Combined vascular defects Truncular forms 
      Arterial or venous 
      Hemolymphatic 
 Extratruncular forms 
      Infiltrating hemolymphatic 
      Limited hemolymphatic 
Table 1. Hamburg classification for congenital vascular malformations (AV, arteriovenous) 
Although the Hamburg classification is currently used worldwide and accepted in most 
clinical settings, further improvements in the CVM classification system will be needed to 
completely replace the old name-based eponyms. 
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2.1.2 Muliken classification 
The Muliken classification is a widely used alternative system which is based on the 
hemodynamic status of the CVM and also provides guidelines for clinical management 
(Mulliken, 1993; Mulliken & Glowacki, 1982). In this classification, all CVMs are divided into 
two types depending on blood flow: fast-flow and slow-flow. It supplies a simple 
understanding for the complex nature of CVM and helps to determine whether treatment is 
needed, as well as treatment modality. Currently, the Muliken classification has been used 
in conjunction with the Hamburg classification in the clinical field. 
2.2 Pathophysiology 
2.2.1 Extratruncular types 
Extratruncular CVMs present by arrest during early embryonic life while the vascular 
system is in the reticular stage (Bastide & Lefebvre, 1989). As such, extratruncular CVMs 
contain the characteristics of mesenchymal cells and have proliferative potential. Therefore, 
all extratruncular CVMs show high risk for exacerbation or recurrence when stimulated or 
treated improperly and can infiltrate and invade the surrounding tissues and show a 
secondary impact, as well as the hemodynamic effect. 
Almost all extratruncular CVMs present with mechanical and hemodynamic effects. For 
example, if the CVM is located in the neck, it may cause airway or esophageal obstruction 
due to the mechanical characteristics of CVM progression. Moreover, the hemodynamic 
effect, particularly the arteriovenous malformation of extratruncular CVM, may result in 
serious complications of the cardiovascular system because the arterial flow directly enters 
the venous drainage system without the resistance of the capillary system. 
2.2.2 Truncular type 
Truncular CVMs occur when developmental arrest happens later during the vascular trunk 
formation stage of embryonic development (Bastide & Lefebvre, 1989). These CVMs have a 
significant risk for hemodynamic complications because the lesions lose their embryonic 
characteristics. If the truncular type of CVM is located in a lower extremity, it may show 
clinical manifestations of lymphedema or chronic venous insufficiency. In addition, if 
arteriovenous malformation presents as the truncular type, life-threatening cardiovascular 
complications, including congestive heart failure, could develop.  
2.3 Diagnosis 
It is impossible for one expert to diagnose the CVM because it has numerous clinical 
manifestations and various diagnostic modalities. For these reasons, a multidisciplinary 
team, composed of a vascular surgeon, a plastic and reconstructive surgeon, an orthopedic 
surgeon, a dermatologist, and an interventional radiologist, is needed to diagnose and 
classify the CVM. In addition to the diagnosis and classification, the CVM treatment plan 
must also be developed by the consensus of the multidisciplinary team. 
2.3.1 CVM versus hemangioma 
Both CVM and hemangioma are grouped as vascular anomalies; however, each anomaly 
presents with completely different behaviors (Lee, 2005).  
By definition, a hemangioma is a vascular tumor that mainly appears at birth and is 
characterized by rapid growth and spontaneous regression. Hemangioma growth starts 
after birth, and spontaneous regression usually occurs before 12 years of age. In comparison 
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to CVM, a rapidly growing hemangioma represents mature endothelium that shows normal 
mitotic activity.  
In general, the differential diagnosis between CVM and hemangioma depends on the 
clinical manifestations and physical examinations. However, if a vascular lesion is the only 
diffuse mass located in the subcutaneous tissue or the muscle layer, diagnosis may be 
impossible and needs to be differentiated. Therefore, tissue confirmation is sometimes 
required in a specific case for the differential diagnosis.  
2.3.2 Clinical manifestations 
CVMs can show a wide range of clinical forms depending on the predominant type and 
location. Most capillary malformations may present as a port-wine stain and can appear 
anywhere in the body as a localized or extensive form. In addition, cutaneous 
manifestations of capillary malformations are associated with anomalies of the soft tissue or 
the skeletal system. For example, hypertrophy of soft tissue and leg bone is expressed with 
cutaneous manifestations in patients with Klippel-Trenaunay syndrome.  
Venous malformations also may present at birth and can be distinctively compressed. Some 
venous malformations located in the skin and the subcutaneous layer of the face or neck 
may cause cosmetic problems, such as disfiguration or asymmetry. Venous malformation in 
the bone can cause a leg length discrepancy due to bone growth disturbances and 
pathologic fractures due to bone destruction. However, if the malformation is located near 
the airway, it has a potential life-threatening risk due to the secondary compression effect 
and intractable bleeding (Figure 3).  
Most lymphatic malformations are asymptomatic except for skin manifestations. Lymphatic 
malformations present as a primary lymphedema (diffuse swelling) or a lymphangioma 
(localized swelling). Complicated lymphatic malformations may lead to non-vascular 
consequences rather than vascular complications, such as the compression of surrounding 
organs, pathologic fractures, or infection.  
Arteriovenous malformations are often indistinct unless complications have developed. The 
direct fistulas between the arteries and the veins are formed in the lesion, and these fistulas 
are represented as the thrill and bruit. Arteriovenous malformation frequently manifests 
several serious complications, including distal ischemia and gangrene due to the shunt, 
intractable bleeding, or high-output cardiac failure.  
2.3.3 Non-invasive tests 
Clinical suspicion is most important for the diagnosis when the baby or child shows the skin 
manifestation or disfigurement. If a CVM is suspected, a detailed history and a physical 
examination are taken. In patients with suspected CVM, non-invasive tests, such as duplex 
ultrasonography, CT or MR angiography, or Tc-99m RBC whole body blood pool 
scintigraphy (WBBPS), can lead to a definite diagnosis in most circumstances. 
Duplex ultrasonography can be examined initially because it provides excellent 
hemodynamic as well as anatomic information. CT or MR angiography shows the exact 
location and the relationship with adjacent tissue, the feeding artery, and the draining vein, 
so it helps to determine the treatment plan. WBBPS can detect another lesion in the body, 
assess the treatment efficacy, and rule out lymphatic malformation (Figure 4). In addition to 
these basic tests, if the patient has a leg-length discrepancy, a bone X-ray should be 
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performed to rule out osseous CVM. When lymphatic malformation is suspected, 
radioisotope lymphoscintigraphy could be added. In arteriovenous malformation, 
transarterial lung perfusion scintigraphy can provide useful information for the general 
impact of an arteriovenous shunt. 
 
 
 
 
Fig. 3. Venous malformation affecting the airway A, Huge venous malformation presents as 
diffuse swelling below the chin. B, T2-weighted MRI images show the airway involvement 
of venous malformation. 
A 
B 
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Fig. 4. Gross appearance and whole body blood pool scan of venous malformation involving 
entire arm. 
2.3.4 Invasive tests 
Currently, most invasive diagnostic tests have been replaced by noninvasive studies because 
the majority of CVMs can be definitely diagnosed by the latter. However, invasive tests, 
such as digital subtraction angiography and venography, remain as a standard and useful 
modality for diagnosing and determining the treatment plan.  
A selective angiography provides a guideline for a treatment method in patients with 
arteriovenous malformations. A venography in conjunction with direct-puncture 
phlebography simultaneously enables the diagnosis and treatment in venous 
malformations. However, traditional percutaneous direct-puncture lymphangiography is 
rarely needed in patients with lymphatic malformations. 
2.4 Treatment 
Until the pathophysiology and biological behavior of CVMs had been characterized, most 
treatment approaches failed to relieve the hemodynamic consequences and secondary 
complications or to cure the CVM itself. Overaggressive treatment due to lack of knowledge 
about various CVMs have also contributed to poor clinical outcomes.  
In the treatment of CVMs, the complete eradication of the nidus provides complete 
curability, but it is rarely possible because most CVMs are infiltrative and located in deeper 
and surgically inaccessible regions.  
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Two decades ago, the Hamburg classification provided a better understanding of the 
anatomy, the pathophysiology, and hemodynamic status of CVMs. Based on this 
classification, new treatment approaches have been developed.  
Previously, we proposed a multidisciplinary team approach composed of 15 clinical 
specialists for diagnosis and treatment.  Surgeons and clinicians in vascular surgery, plastic 
and reconstructive surgery, pediatric surgery, interventional and diagnostic radiology, 
nuclear medicine, orthopedic surgery, head and neck surgery, oral-maxillary surgery, 
anesthesiology, vascular medicine, pathology, physical medicine and rehabilitation, 
psychiatry, and dermatology should all be represented (Lee, 2005). This team has been 
operated effectively by a ‘referral system’ to diagnose, develop a treatment plan, and 
manage the consequence after treatment.  
All CVMs may not require treatment and a poorly planned treatment could awake the 
quiescent stage of CVM. In particular, aggressive treatment for CVM should be considered 
when the CVM is associated with symptoms such as hemorrhage, high-output heart failure, 
disabling pain, cosmetically severe deformity, etc.  
2.4.1 Surgical treatment 
Although surgical resection provides the only complete curable option, it is rarely indicated 
because of the extensive nature and high morbidity and recurrence of CVMs. Complete 
resection is limited to superficially isolated lesions without invasion into deeper structures, 
such as muscle, nerve, and bone. Incomplete resection of the nidus or ligation of the feeding 
artery without removal of the nidus may result in the faster growth of quiescent 
malformations (Kim et al., 2006). Therefore, only selective cases have been recommended for 
surgical removal.  
If a surgical resection is planned, preoperative embolization using ethanol, ethanolamine 
oleate, or N-butyl cyanoacrylate (NBCA) helps to delineate the extent of surgery and reduce 
intra-operative bleeding. 
In conclusion, surgical approach for CVM should be considered carefully and planned 
perfectly because it has a potential to exacerbate the manifestations of CVM, as well greatly 
increasing risk for complications and recurrence. 
2.4.2 Endovascular treatment 
As previously described, surgical intervention for most CVMs is not an option due to 
location and infiltrative nature. The new concepts of “endovascular treatment” to treat 
CVMs or to control symptoms have been developed by the multidisciplinary team 
approach. Endovascular treatment, composed of embolization and sclerotherapy, is now 
well accepted as an effective treatment modality for CVMs, the diffuse type of 
extratruncular form in particular.  
Several sclerosing agents have been used in the clinical setting. First, absolute ethanol is the 
most effective sclerosing agent to treat the CVM itself or to control the secondary 
consequences caused by the CVM. Ethanol can be delivered by an endovascular approach or 
administered by a direct puncture technique (Figure 5). However, acute caution is required 
when the ethanol is delivered into circulatory system via malformed vessels. The ethanol 
increases pulmonary arterial pressure and can, in the worst case, cause a pulmonary artery 
spasm and subsequent cardiopulmonary arrest. In addition, it can directly damage the 
surrounding tissues, including skin, soft tissue, nerve, tendon, muscle, and bone, and cause 
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cosmetic problems and functional complications. Therefore, close monitoring of the 
cardiopulmonary system, including the pulmonary artery wedge pressure, is absolutely 
necessary during and immediately after the embolo/sclerotherapy. Embolo/sclerotherapy 
using ethanol should be performed only when the therapeutic benefits are considered to 
outweigh the risks.  
 
 
Fig. 5. Embolo/sclerotherapy by direct puncture technique in patient with arteriovenous 
malformation in the hand.  
NBCA as an independent agent is not an ideal treatment for the diffuse and infiltrative 
types of CVM, but preoperative NBCA embolo/sclerotherapy assists in hemorrhage 
minimization during the surgical excision of CVM. Safer alternative agents, such as 
ethanolamine, polidocanol, and sodium tetradecyl sulfate, are currently being used and 
assessed in the control of CVM symptoms, particularly venous malformation  
3. Congenital vascular malformations: Skin and soft tissue injuries 
Embolo/scleotherapy may be an effective treatment modality for most CVMs, especially the 
diffuse infiltrating type of extratruncular CVM, due to the low recurrence and acceptable 
morbidity. Thus, the embolo/sclerotherapy is the main strategy utilized to treat the CVM itself 
and control secondary symptoms when complete surgical excision is not a viable option. 
www.intechopen.com
 Skin and Soft Tissue Injuries in Congenital Vascular Malformations 
 
91 
However, few reports exist for the incidence and treatment of skin and soft tissue injuries 
developed after embolo/sclerotherapy in patients with CVMs. In addition, it is unknown 
which types of CVMs are more susceptible to skin and soft tissue injuries and which 
treatment methods are the most successful for these injuries.  
We previously reported the incidence of skin and soft tissue injury after 
embolo/scleorotherapy for CVM and reviewed the prognosis according to the treatment 
modalities in patients with skin and soft tissue injuries (Lee et al., 2008). This chapter, based 
on our study, has described the outcomes according to treatment methods in patients with 
skin and soft tissue injuries developed after embolo/sclerotherapy. 
3.1 Incidence 
A retrospective review of 1,823 patients with a CVM, 573 of whom were managed by a 
multidisciplinary approach of embolo/sclerotherapy, was performed. Absolute or 80% 
ethanol, ethanolamine oleate, NBCA, or various types of coils or contour particles were used 
as the embolo/sclerosing agents based on the location, the severity, and the extent of the 
CVM. 
Our study indicated that skin and soft tissue injuries occurred in 11.9% of patients (n = 68). 
Yun et al. (2009) also demonstrated that the incidence of skin necrosis after percutaneous 
ethanol sclerotherapy in venous malformations was 8%. However, Jin et al. (2008) reported 
that only 6 sessions of tissue necrosis (1%) among 592 sclerotherapy sessions. The necrosis 
developed in the finger tips after 5 treatment sessions and in the chin area after 1 treatment 
session. They reported that all lesions were spontaneously healed. We thought that lower 
incidence of tissue necrosis was due to ethanol usage only for sclerosis of the draining vein 
of venous malformations. 
In our study, skin and soft tissue injuries occurred in 15.6% of those that used ethanol, in 
6.3% of those that used ethanolamine oleate, and in 8.3% of those that used glue (Lee et al., 
2008). The incidence of skin and soft tissue injuries after embolo/sclerotherapy according to 
the Hamburg classification is described in Table 2. 
First of all, our study indicated there were no skin and soft tissue injuries in patients with 
the truncular forms of CVMs (Lee et al., 2008). Moreover, embolo/sclerotherapy for 
extratruncular forms of arterial and lymphatic malformations did not lead to skin and soft 
tissue injuries. In addition, embolo/sclerotherapy in patients with extratruncular type of 
arteriovenous shunting types was correlated with the largest portion of skin and soft tissue 
injuries (n = 42/142) and these injuries showed similar rates for both the infiltrating and the 
limited types (30.6% vs. 26.7%). Skin and soft tissue injuries were more common in the 
infiltrating type than in the limited type of the extratruncular form (13.2% vs. 9.7%) of the 
CVMs. Based on the location of the CVMs, the incidence of skin and soft tissue injuries was 
20.4% in the upper extremities, 14.3% in the lower extremities and the perineum/genitalia, 
9.1% in the pelvis, 7.5% in the head and neck, and 6.4% in the thorax. Among all skin and 
soft tissue injuries, only one occurred in a patient with a venous malformation which 
involved the tongue and lip. 
In conclusion, our study suggested that the extratruncular form of arteriovenous 
shunting malformation and the extratruncular form of venous malformation were more 
susceptible to skin and soft tissue injuries after embolo/sclerotherapy in patients with 
CVMs. 
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Types of CVM 
(n=573) 
Forms of CVM 
(n=573) 
Skin and soft tissue injuries 
(n=68) 
Arterial (n=1) Truncular (n=0) 0 (0%) 
 Extratruncular (n=1) 0 (0%) 
      Limited (n=1)  
      Infiltrating (n=0)  
Venous (n=273) Truncular (n=1) 0 (0%) 
 Extratruncular (n=272) 22 (32.4%) 
      Limited (n=57) 6 
      Infiltrating (n=215) 16 
Lymphatic (n=102) Truncular (n=4) 0 (0%) 
 Extratruncular (n=98) 0 (0%) 
      Limited (n=80)  
      Infiltrating (n=18)  
AV shunting (n=143) Truncular (n=1) 0 (0%) 
 Extratruncular (n=142) 42 (61.8%) 
      Limited (n=45) 12 
      Infiltrating (n=97) 30 
Combined (n=54) Truncular (n=1) 0 (0%) 
 Extratruncualr (n=53) 4 (5.9%) 
      Limited (n=13) 1 
      Infiltrating (n=40) 3 
Table 2. Patients with skin and soft tissue injuries after embolo/sclerotherapy according to 
Hamburg classification in patients with congenital vascular malformations. (CVM, 
congenital vascular malformation; AV, arteriovenous) 
3.2 Treatment and outcome 
The treatment strategy for skin and soft tissue injuries was developed after 
embolo/sclerotherapy was decided by multidisciplinary team and was determined by the 
extent, the depth, and the severity of the injury. First, conservative management such as a 
simple dressing was applied, but the infected wound was managed by antibiotics, surgical 
debridement, and drainage. If the eschar led to the contracture, then escharectomy has been 
performed to relieve the contracture and recover the joint motion. The skin and soft tissue 
injuries did not heal with conservative management or those that involved deeper 
structures, such as muscles or tendons, have subsequently required plastic reconstructive 
surgery. In the extremities, severe injuries with extensive necrosis in deeper tissue, severe 
deformity or pain, or functional disabilities were amputated (Figure 6). 
As a result, 40 of 68 patients (58.8%) with skin and soft tissue injuries have been healed by 
conservative management and 18 escharectomies (26.5%) and 4 amputations (5.9%) were 
performed (Lee et al., 2008). As a result of embolo/sclerotherapy, all patients who needed 
amputation had the infiltrating arteriovenous shunting extratruncular type.  
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Fig. 6. A, Necrosis of 3rd fingertip after embolo/sclerotherapy in patient with arteriovenous 
malformation. B, After 3rd finger amputation. 
In our study, plastic reconstructive surgeries, including split-thickness or full-thickness skin 
grafts, were performed in 6 of 68 patients (8.8%) with skin and soft tissue injuries (Lee et al., 
2008). The characteristics of the patients who underwent skin grafts and the clinical 
outcomes are described in Table 3. 
 
No. Type of CVM 
Form of 
CVM 
Type of 
sclerosant (ml) 
Location 
of injury 
Method of 
skin graft 
Outcome 
1 AV shunting ET Pure ethanol(12) Ear FTSG Completely healed 
2 AV shunting ET 
Pure 
ethanol(40.5) 
Knee STSG Completely healed 
3 AV shunting ET 
Pure 
ethanol(6.75) 
Hand STSG Completely healed 
4 AV shunting ET NBCA(12) Occiput STSG Completely healed 
5 Venous ET Pure ethanol(18) Arm STSG Completely healed 
6 Venous ET 
Pure 
ethanol(20.5) 
Arm STSG Completely healed 
Table 3. The characteristics and the outcome for 6 skin and soft tissue injuries that were 
performed skin graft. (CVM, congenital vascular malformation; AV, arteriovenous; ET, 
extratruncular; NBCA, N-butyl cyanoacrylate; FTSG, full-thickness skin graft; STSG, split-
thickness skin graft) 
Two plastic surgeries were performed in the injuries that developed as a result of 
embolo/sclerotherapy for the infiltrating venous extratruncular types, 1 for the limited 
arteriovenous extratruncular type, 3 for the infiltrating arteriovenous shunting 
extratruncular type. All plastic reconstructive surgeries were performed only if the injured 
wound had not healed with conservative management or involved deeper structures and all 
skin grafts could be successfully performed (Figure 7). 
A B 
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Fig. 7. A, Split-thickness skin graft in patient with skin and soft tissue injury in the palm 
after pure ethanol embolo/sclerotherapy. B, Full-thickness skin graft in patient with necrosis 
of the ear after pure ethanol embolo/sclerotherapy. 
4. Conclusions 
CVMs are relatively uncommon congenital anomalies and difficult to be distinguished from 
other vascular conditions, such as a simple birthmark or a hemangioma. In addition, the 
CVMs show numerous clinical manifestations according to the involved vascular system, 
the location, and the extent, and additionally require variable clinical responses depending 
on the manifestation.  
Although much effort has been made to accurately diagnose and completely treat CVMs, 
they still remain challenging even to a specialist. Therefore, a multidisciplinary team 
composed of specialists from many surgical and clinical disciplines is absolutely needed to 
develop a successful strategy for the treatment modality and management of complications 
after treatment. 
As a current treatment method for CVMs, embolo/sclerotherapy has become a mainstay 
because in most CVMs it is impossible to completely remove the nidus. Even if 
embolo/sclerotherapy has been proven a relatively safe and effective treatment modality in 
most patients with CVM, our study indicated that skin and soft tissue injuries occurred with 
relatively high frequency in patients undergoing embolo/sclerotherapy. In particular, our 
results suggested that the extratruncular forms of the arteriovenous shunting malformation 
and the venous malformation require acute vigilance for signs of skin and soft tissue injuries 
in patients undergoing embolo/sclerotherapy, even though most injuries were completely 
healed with conservative management.  
Additionally, skin grafts may be the best treatment option for most skin and soft tissue 
injuries unable to be healed by conservative management or involved beyond the muscle 
layer after embolo/sclerotherapy in patients with CVMs.  
B 
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The procedure of skin grafting has been performed since 3000BC and with the aid of modern technology has
evolved through the years. While the development of new techniques and devices has significantly improved
the functional as well as the aesthetic results from skin grafting, the fundamentals of skin grafting have
remained the same, a healthy vascular granulating wound bed free of infection. Adherence to the recipient bed
is the most important factor in skin graft survival and research continues introducing new techniques that
promote this process. Biological and synthetic skin substitutes have also provided better treatment options as
well as HLA tissue typing and the use of growth factors. Even today, skin grafts remain the most common and
least invasive procedure for the closure of soft tissue defects but the quest for perfection continues.
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